Department of Family Medicine, University of Montréal, Montréal, Canada.
Department of Psychology, University of Bourgogne, Dijon, France.
Pediatr Pulmonol. 2020 Feb;55(2):468-473. doi: 10.1002/ppul.24581. Epub 2019 Nov 25.
While long-term sequelae of acute respiratory distress syndrome (ARDS) are well-documented in adults, few studies reported post-discharge respiratory complications in pediatric ARDS (PARDS) and none used the recent Pediatric Acute Lung Injury Consensus Conference (PALICC) diagnostic criteria. This study describes the respiratory symptoms, pulmonary function, and health resource use of PARDS survivors at 3 months post-discharge.
Retrospective study.
Children less than 18 years admitted to the intensive care unit of Sainte-Justine University Health Center from 1st September 2015 to 1st July 2017, and meeting PALICC diagnostic criteria for PARDS.
We evaluated 38 of the 44 children with PARDS in the follow-up clinic at a mean (SD) of 3.4 (2.0) months post-discharge for respiratory symptoms, age-appropriate pulmonary function tests (spirometry or oscillometry, maximal respiratory pressures), and all-cause emergency department (ED) visits or rehospitalizations since discharge.
Fourteen (36.8%) had abnormal respiratory symptoms (most commonly cough between respiratory infections and wheezing), 7 of whom (18.4%) presented new respiratory symptoms since PARDS diagnosis. A mild-to-moderate restrictive pattern was observed in 3 of 10 patients who performed spirometry and mildly decreased maximal inspiratory pressures were noted in 2 of 8 patients who performed these maneuvers. Nine (23.7%) patients consulted in the ED and 4 (10.5%) were rehospitalized post-discharge.
Despite our cohort's limited sample size, our findings suggest that a significant proportion of PARDS survivors experience abnormal respiratory symptoms, pulmonary function deficits, and recurrent problems requiring medical attention. Larger, multicenter studies are required to identify risk factors associated with poor post-discharge outcomes among PARDS survivors.
急性呼吸窘迫综合征(ARDS)的长期后遗症在成人中已有充分记录,但很少有研究报告儿科 ARDS(PARDS)出院后的呼吸并发症,也没有使用最近的儿科急性肺损伤共识会议(PALICC)诊断标准。本研究描述了 PARDS 幸存者出院后 3 个月的呼吸症状、肺功能和卫生资源利用情况。
回顾性研究。
2015 年 9 月 1 日至 2017 年 7 月 1 日期间入住 Sainte-Justine 大学健康中心重症监护病房且年龄小于 18 岁,并符合 PALICC 诊断标准的 PARDS 患儿。
我们在出院后平均(标准差)3.4(2.0)个月时,在随访诊所评估了 44 名 PARDS 患儿中的 38 名,评估内容包括呼吸症状、适合年龄的肺功能测试(肺活量计或振荡法、最大呼吸压力)以及出院后所有原因的急诊就诊或再次住院。
14 名(36.8%)患儿出现异常呼吸症状(最常见的是呼吸道感染时咳嗽和喘息),其中 7 名(18.4%)自 PARDS 诊断以来出现新的呼吸症状。10 名接受肺活量计检查的患儿中有 3 名存在轻度至中度限制性模式,8 名接受这些操作的患儿中有 2 名存在最大吸气压力轻度降低。9 名(23.7%)患儿在急诊就诊,4 名(10.5%)患儿出院后再次住院。
尽管我们的队列样本量有限,但我们的研究结果表明,很大一部分 PARDS 幸存者存在异常呼吸症状、肺功能缺陷和需要医疗关注的反复问题。需要更大的、多中心的研究来确定与 PARDS 幸存者出院后不良结局相关的危险因素。